Blizzy Code Covid 19 Situation Update
- Communicable disease threats report, Week 13, 26 March - 1 April 2023
- Communicable disease threats report 19 - 25 March, Week 12
- Conducting after-action reviews of the public health response to COVID-19
- Conducting after-action reviews of the public health response to COVID-19: update
- Communicable disease threats report, Week 11, 12-18 March 2023
- Communicable Disease Threats Report Week 10, 5–11 March 2023
- Communicable disease threats report, week 9, 27 February - 5 March 2023
- ECDC de-escalates BA.2, BA.4 and BA.5 from its list of variants of concern
- SARS-CoV-2 in animals: susceptibility of animal species, risk for animal and public health, monitoring, prevention and control
- Communicable disease threats report, week 8, 19-25 February 2023
- Earthquakes in Türkiye and Syria: infectious diseases expected to be a concern in two to four weeks
- Communicable disease threats report, week 7, 12-18 February 2023
- Communicable disease threats report, Week 6, 5-11 February 2023
- Healthcare facilities should maintain and strengthen infection prevention and control measures during peaks of respiratory viruses transmission
- Considerations for infection prevention and control practices in relation to respiratory viral infections in healthcare settings
- COVID-19 Vaccine Effectiveness
- International Travel to and from the United States
- V-safe After Vaccination Health Checker
- People with Certain Medical Conditions
- Global COVID-19
- Ensuring COVID-19 Vaccine Safety in the US
- Benefits of Getting A COVID-19 Vaccine
- Myths and Facts about COVID-19 Vaccines
- COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised
- Long COVID or Post-COVID Conditions
- Overview of COVID-19 Vaccines
- Centers for Disease Control and Prevention
- Understanding Risk
- Isolation and Precautions for People with COVID-19
- Understanding Exposure Risks